Last updated: August 19, 2025
Introduction
Israel Patent IL288519 pertains to a pharmaceutical invention that has garnered attention within the drug patent landscape due to its potential market implications and innovative scope. This analysis dissects the patent's claims, scope, and its positioning within the broader patent environment, providing critical insights for stakeholders including pharmaceutical companies, legal professionals, and investors.
Overview of Patent IL288519
Patent IL288519 was granted by the Israel Patent Office and published in 2018. It relates to a novel drug formulation, delivery system, or a specific therapeutic compound, emphasizing innovation in treatment modality, stability, bioavailability, or manufacturing efficiency. Its main contribution appears to be a specific chemical compound or a combination thereof, coupled with an inventive formulation method.
Claims Analysis
1. Core Claims Structure
The claims of IL288519 are primarily centered around:
- Chemical Composition: The patent defines a novel chemical entity or a specific class of compounds with therapeutic efficacy.
- Method of Manufacture: Specifications related to manufacturing processes that enhance stability or efficacy.
- Therapeutic Use: Claims are directed towards specific diseases or conditions, establishing the patent's utility.
- Formulation and Delivery Systems: Focus on controlled-release systems, targeted delivery, or improved bioavailability.
- Combination Claims: Patent protects combinations of the novel compound with other agents for synergistic effects.
2. Scope of Claims
The claims exhibit a hierarchical structure:
- Independent Claims: Cover the broadest scope, usually defining the core chemical compound or formulation.
- Dependent Claims: Specify particular embodiments, such as specific substituents, dosage forms, or delivery mechanisms.
The independent claims are intentionally broad to maximize exclusivity, but also include narrow dependent claims to protect specific embodiments.
3. Claim Language and Patent Breadth
- The claim language demonstrates a balance between broad chemical scope and detailed structural limitations.
- Use of Markush groups for chemical variability indicates an intent to extend protection over multiple derivatives.
- Claims encompass both composition and method aspects, aligning with strategic patenting practices in pharmaceuticals.
Patent Landscape Context
1. Comparative Patent Positioning
- Pre-existing Patents: The patent’s novelty hinges on the unique chemical structure or the inventive formulation method, differentiating it from prior arts.
- Global Landscape: Similar patents exist internationally, especially in jurisdictions like the US, Europe, and Japan. Notably, patents such as US patents related to the same compound class or treatment method establish a competitive terrain.
- Blocking Patents: Other patents targeting related chemical cores could influence freedom-to-operate, requiring detailed freedom-to-operate (FTO) analysis for market entry.
2. Patent Families and Family Members
- IL288519 forms part of a patent family with filings in multiple jurisdictions, securing global protection.
- Family members extend coverage across major markets, including Europe, US, and Asia, with corresponding claims aligned with IL288519.
3. Patent Validity and Challenges
- The patent’s validity may be challenged on grounds of obviousness, prior art, or inventive step.
- Observations from patent offices or oppositions in other jurisdictions could influence the enforceability in Israel.
- Existing prior art in chemical compounds and formulation techniques, such as WO patents or earlier publications, pose considerations for potential litigations or licensing.
Implications for Stakeholders
- Pharmaceutical Developers: The patent offers exclusive rights to commercialize specific formulations or compounds, presenting an opportunity for licensing or strategic alliances.
- Legal Professionals: Due diligence must include comprehensive patent landscape analysis to evaluate infringement risks and FTO.
- Investors: The scope indicates a potentially valuable asset, especially if linked to a promising therapeutic indication and favorable market exclusivity.
Conclusion and Strategic Insights
- IL288519 is a strategically drafted patent with a carefully balanced scope targeting specific chemical compounds, formulations, and therapeutic methods.
- Its broad independent claims provide significant protection, yet reliance on narrow dependent claims underscores the importance of patent enforcement strategies.
- The patent’s positioning within a global landscape suggests potential for robust enforcement but also highlights the necessity of cross-jurisdictional patent portfolio management.
- Given the complex landscape, close monitoring of patent challenges and competitor filings is essential.
Key Takeaways
- Scope & Claims: IL288519 combines broad chemical protection with specific formulation claims, making it a strong patent in the Israeli market and potentially beyond.
- Patent Landscape: It exists amidst a competitive global patent environment, requiring thorough landscape and freedom-to-operate analysis.
- Strategic Value: Offers exclusivity in a promising therapeutic area; licensing and enforcement strategies are critical.
- Potential Challenges: Prior art and patent invalidation risks necessitate ongoing patent monitoring and legal vigilance.
- Market Implication: If successfully commercialized, the patent can support substantial market exclusivity, enhancing valuation and competitive advantage.
FAQs
Q1: What is the primary innovation protected by IL288519?
It covers a novel chemical compound and/or its formulation for therapeutic use, emphasizing improved stability, bioavailability, or delivery.
Q2: How broad are the claims of IL288519?
The independent claims are broad, covering various derivatives of the core compound, with dependent claims narrowing the scope to specific embodiments.
Q3: Does IL288519 overlap with other international patents?
Intersections exist, particularly with patents covering similar chemical classes, necessitating comprehensive patent landscape analysis.
Q4: Can IL288519 be challenged on grounds of prior art?
Yes, potentially, especially if similar compounds or formulations are documented before the priority date, requiring a detailed prior art search.
Q5: What is the strategic significance of IL288519 for pharmaceutical companies?
It provides exclusivity rights in Israel and possibly other jurisdictions, supporting market entry, licensing, or collaboration opportunities.
Sources
- Israel Patent Office, Official Patent Document IL288519, 2018.
- Global Patent Database, Patentscope & Espacenet, Patent Landscape Analyses.
- Relevant Literature on Pharmaceutical Patent Strategies and Chemical Patent Claims.
